Literature DB >> 21364080

MR-compatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions.

Stephan Zangos1, Andreas Melzer, Katrin Eichler, Cyrus Sadighi, Axel Thalhammer, Boris Bodelle, Renate Wolf, Tatjana Gruber-Rouh, Dirk Proschek, Renate Hammerstingl, Cindy Müller, Martin G Mack, Thomas J Vogl.   

Abstract

PURPOSE: To examine the feasibility and safety of magnetic resonance (MR)-guided biopsy by using a transgluteal approach in patients with suspicious prostate lesions by using an MR-compatible robotic system and a 1.5-T MR system.
MATERIALS AND METHODS: The study was approved by the institutional review board of University Frankfurt, and informed consent was obtained from each patient. A total of 20 patients (age range, 57.8-71.9 years; mean age, 65.1 years) underwent biopsy in a closed-bore high-field-strength MR system. Biopsy was performed with an MR-compatible pneumatically driven robotic system. T1-weighted gradient-echo fast low-angle shot and T2-weighted true fast imaging with steady-state precession sequences were used to plan and guide the intervention with a transgluteal access on the external planning computer of the assistance system. The system calculated the trajectory and then moved the guiding arm to the insertion point. The cannula was advanced manually, and biopsies were performed with the coaxial technique by using a 15-gauge pencil tip needle. Intervention time, complications, and biopsy findings were documented.
RESULTS: The MR-compatible robotic system did not interfere with image quality, nor did MR imaging cause dysfunction of the robot. In one patient, the interventionist caused a fail-safe system shutdown. This was due to inadvertent displacement of the guiding arm during cannula insertion. This problem was solved by increasing the displacement threshold. Accurate coaxial cannula biopsy could be performed in all subsequent patients. Sufficient histopathologic assessment was performed in 19 patients. Insufficient material was retrieved in the patient who experienced fail-safe system shutdown. The median intervention time was 39 minutes (23-65 minutes). No procedure-related complications were observed.
CONCLUSION: Preliminary results indicate that MR-guided robot-assisted biopsy is feasible and can be performed safely with highly accurate cannula placement. RSNA, 2011

Entities:  

Mesh:

Year:  2011        PMID: 21364080     DOI: 10.1148/radiol.11101559

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  34 in total

Review 1.  Robotic prostate biopsy and its relevance to focal therapy of prostate cancer.

Authors:  Henry Ho; John S P Yuen; Christopher W S Cheng
Journal:  Nat Rev Urol       Date:  2011-09-20       Impact factor: 14.432

Review 2.  Image-guided robotic interventions for prostate cancer.

Authors:  Ashwin N Sridhar; Archie Hughes-Hallett; Erik K Mayer; Philip J Pratt; Philip J Edwards; Guang-Zhong Yang; Ara W Darzi; Justin A Vale
Journal:  Nat Rev Urol       Date:  2013-06-18       Impact factor: 14.432

3.  3T MR-guided in-bore transperineal prostate biopsy: A comparison of robotic and manual needle-guidance templates.

Authors:  Gaurie Tilak; Kemal Tuncali; Sang-Eun Song; Junichi Tokuda; Olutayo Olubiyi; Fiona Fennessy; Andriy Fedorov; Tobias Penzkofer; Clare Tempany; Nobuhiko Hata
Journal:  J Magn Reson Imaging       Date:  2014-09-27       Impact factor: 4.813

4.  An Integrated Robotic System for MRI-Guided Neuroablation: Preclinical Evaluation.

Authors:  Niravkumar A Patel; Christopher J Nycz; Paulo A Carvalho; Katie Y Gandomi; Radian Gondokaryono; Gang Li; Tamas Heffter; Everette Clif Burdette; Julie G Pilitsis; Gregory S Fischer
Journal:  IEEE Trans Biomed Eng       Date:  2020-02-17       Impact factor: 4.538

5.  Accuracy and speed of robotic assisted needle interventions using a modern cone beam computed tomography intervention suite: a phantom study.

Authors:  Boris Schulz; Katrin Eichler; Petra Siebenhandl; Tatjana Gruber-Rouh; Christoph Czerny; Thomas Josef Vogl; Stephan Zangos
Journal:  Eur Radiol       Date:  2012-07-21       Impact factor: 5.315

Review 6.  MRI-guided biopsy for prostate cancer detection: a systematic review of current clinical results.

Authors:  Christiaan G Overduin; Jurgen J Fütterer; Jelle O Barentsz
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

7.  Configurable automatic detection and registration of fiducial frames for device-to-image registration in MRI-guided prostate interventions.

Authors:  Junichi Tokuda; Sang-Eun Song; Kemal Tuncali; Clare Tempany; Nobuhiko Hata
Journal:  Med Image Comput Comput Assist Interv       Date:  2013

8.  MR Safe Robot, FDA Clearance, Safety and Feasibility Prostate Biopsy Clinical Trial.

Authors:  Dan Stoianovici; Chunwoo Kim; Doru Petrisor; Changhan Jun; Sunghwan Lim; Mark W Ball; Ashley Ross; Katarzyna J Macura; Mohamad Allaf
Journal:  IEEE ASME Trans Mechatron       Date:  2016-10-20       Impact factor: 5.303

9.  Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.

Authors:  Soroush Rais-Bahrami; Baris Turkbey; Kinzya B Grant; Peter A Pinto; Peter L Choyke
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

Review 10.  Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.

Authors:  Jennifer K Logan; Soroush Rais-Bahrami; Baris Turkbey; Andrew Gomella; Hayet Amalou; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  BJU Int       Date:  2014-05-22       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.